USPTO Office Action Rejects Claims Of Umbilical-Cord Patents

In a move that could bode well for biotechnology company ViaCell Inc. in a long-running battle between umbilical-cord blood banks, the U.S. Patent and Trademark Office has issued a first office...

Already a subscriber? Click here to view full article